Belantamab mafodotin,Pomalidomide,Dexamethasone
GSK
['dexamethasone', 'pomalidomide', 'dreamm', 'dreamm-3', 'belantamab,mafodotin', 'mmsm', 'belantamab']
#eha2023 | meletios a. dimopoulos, shares data from the dreamm-3 trial of belantamab mafodotin vs pomalidomide plus dexamethasone for rrmm. median pfs 11.2mo vs 7.2mo. pfs hr not significant. orr 41% vs 36% in belamaf and pd. #mmsm #myeloma 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma